ABVC BioPharma, Inc. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
ABVC BioPharma, Inc. (ABVC) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of -$203.62 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2023-05-15
- ABVC BioPharma, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2023-03-31 was -$203.62K.
- ABVC BioPharma, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2022-03-31 was -$113.29K.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 2 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month |
|---|---|---|---|
| 2023-03-31 | -$203.62K 10-Q · filed 2023-05-15 | ||
| 2022-03-31 | -$113.29K 10-Q · filed 2023-05-15 | ||
| 2016-06-30 | -$300.00K 10-Q · filed 2016-08-15 | ||
| 2015-09-30 | $300.00K 10-Q · filed 2016-08-15 |